Download PDF
Thromb Haemost 1968; 20(01/02): 144-154
DOI: 10.1055/s-0038-1651255
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

A Circulating Anticoagulant Directed against Antihaemophilic Globulin (Factor VIII) Combined with Thrombocytopenia

Report of a Case Successfully Treated by an Immunosuppressive Agent[*]
G Winckelmann
1   Department of Medicine (Commiss. Director: Prof. Dr. J. Schirmeister), University of Freiburg, Germany
,
D Böttcher
1   Department of Medicine (Commiss. Director: Prof. Dr. J. Schirmeister), University of Freiburg, Germany
,
R Groh
1   Department of Medicine (Commiss. Director: Prof. Dr. J. Schirmeister), University of Freiburg, Germany
,
with Technical Assistance by M. Rehe › Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

  PDF Download  Permissions and Reprints

Summary

A circulating anticoagulant directed against factor VIII (antihaemophilic globulin) is described which developed in association with thrombocytopenia in an otherwise apparently healthy woman. Inactivation of factor VIII by this inhibitor was shown to be progressive and temperature dependent. The circulating anticoagulant was not species specific and produced temporary factor VIII deficiency when injected into dogs. Administration of large doses of corticosteroids to the patient did not affect the factor VIII inhibitor and resulted only in a temporary increase in the platelet counts. In the course of subsequent immunosuppressive treatment with azathioprine, the inhibitor disappeared and clinical symptoms improved, whereas thrombocytopenia persisted.

* Supported in part by a grant from Kuratorium der Wissenschaftlichen Gesellschaft Freiburg i. Br.


 

  • References

  • 1 Andersen B.R, Terry W.D. Gamma G4-globulin antibody causing inhibition of clotting factor VIII. Nature (Lond.) 1968; 217: 174-175
    CrossrefPubMedGoogle Scholar
  • 2 Bachmann F, Duckert F, Koller F. The Stuart-Prower factor assay and its clinical significance. Thrombos. Diathes. haemorrh. (Stuttg.) 1958; 2: 24-38
    PubMedGoogle Scholar
  • 3 Barkhan P. Observations on a coagulation defect characterized by thrombocytopenia with a circulating anticoagulant. S. Afr. J. med. Sci 1952; 17: 87-89
    PubMedGoogle Scholar
  • 4 Benthaus J. Über die Retraktion des Blutgerinnsels. Thrombos. Diathes. haemorrh. (Stuttg.) 1959; 5: 311-347
    PubMedGoogle Scholar
  • 5 Bidwell E, Benson K.W.E, Dike G.W.R, Augustin R, Lloyd G.M. Antibody nature of the inhibitor to antihaemophilic globulin (factor VIII). Nature (Lond.) 1966; 210: 746-747
    CrossrefPubMedGoogle Scholar
  • 6 Biggs R, Douglas A.S. The thromboplastin generation test. J. clin. Path 1953; 6: 23-29
    CrossrefPubMedGoogle Scholar
  • 7 Biggs R, Bidwell E. A method for the study of antihaemophilic globulin inhibitors with reference to six cases. Brit. J. Haemat 1959; 5: 379-395
    CrossrefPubMedGoogle Scholar
  • 8 Biggs R, Denson K.W.E, Nossel H.L. A patient with an unusual circulating anticoagulant. Thrombos. Diathes. haemorrh. (Stuttg.) 1964; 12: 1-11
    PubMedGoogle Scholar
  • 9 Bläker F, Fischer K, Landbeck G. Entwicklung von Hemmkörpern nach langfristiger Substitution von humanem antihämophilen Globulin bei schwerer Hämophilie A. Klin. Wschr 1967; 45: 630-633
    CrossrefPubMedGoogle Scholar
  • 10 Bonnin J.A, Cohen A.K, Hicks N.D. Coagulation defects in a case of systemic lupus erythematosus with thrombocytopenia. Brit. J. Haemat 1956; 2: 168-179
    CrossrefPubMedGoogle Scholar
  • 11 Borchgrevink C.F. A method for measuring platelet adhesiveness in vivo. Acta med. scand 1960; 168: 157-164
    PubMedGoogle Scholar
  • 12 Borchgrevink C.F, Waaler B.A. The secondary bleeding time. A new method for the differentiation of hemorrhagic diseases. Acta med. scand 1958; 162: 362-374
    PubMedGoogle Scholar
  • 13 Breckenridge R.T, Ratnoff O.D. Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for antihemophilic factor. Blood 1962; 20: 137-149
    PubMedGoogle Scholar
  • 14 Van Grefeld S, Hoorweg P.G, Paulssen M.M.P. Researches on a circulating anticoagulant in a hemophiliac, II. Effect of administration of ACTH and cortisone. Blood 1953; 8: 125-130
    PubMedGoogle Scholar
  • 15 Dausset J. Les anticoagulants circulants sontils des anticorps?. Sang 1959; 30: 428-441
    PubMedGoogle Scholar
  • 16 Deutsch E. Acquired inhibitors. Thrombos. Diathes. haemorrh. (Stuttg.) 1962; 7: 112-128 Suppl. 1 ad
    PubMedGoogle Scholar
  • 17 Deutsch E, Frischauf H, Keibl E. Hemmkörperhämophilie als Komplikation bei essentieller Thrombopenie. Acta haemat. (Basel) 1951; 6: 156-173
    CrossrefPubMedGoogle Scholar
  • 18 Ehrenworth L. Spontaneously occurring anticoagulant against antihemophilic globulin in a previously normal subject. Amer. J. Med 1963; 34: 272-280
    CrossrefPubMedGoogle Scholar
  • 19 Favry-Gilly J, Thouverez J.P. Les inhibiteurs de la première phase de la coagulation en dehors de l’hémophilie. Sang 1959; 30: 351-376
    PubMedGoogle Scholar
  • 20 Feissly R, Lüdin H. Microscopie par contrastes de phases, III. Applications à l’hématologie. Rev. Hémat 1949; 4: 481-501
    PubMedGoogle Scholar
  • 21 Goudemand M.L, Foucaut M, Hutin A, Parquet-Gernez A. Les anticoagulants circulants anti-facteur VIII au cours de l’hémophilie A (nature et méchanisme d’action). Nouv. Rev. franç, hémat 1963; 3: 703-722
    PubMedGoogle Scholar
  • 22 Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin. Wschr 1948; 26: 577-583
    CrossrefPubMedGoogle Scholar
  • 23 Horowitz H.I, Fujimoto M.M. Acquired hemophilia due to a circulating anticoagulant. Report of two cases, with review of the literature. Amer. J. Med 1962; 33: 501-509
    CrossrefPubMedGoogle Scholar
  • 24 Lee S.L, Sanders M. A disorder of blood coagulation in systemic lupus erythematosus. J. clin. Invest 1955; 34: 1814-1822
    CrossrefPubMedGoogle Scholar
  • 25 Lopaciuk S, Naleczynska A, Czaja H, Walewska I, Pawelski S. Circulating anticoagulant against factor VIII coexistent with some immunological reactions in a female. Thrombos. Diathes. haemorrh. (Stuttg.) 1964; 11: 444-451
    PubMedGoogle Scholar
  • 26 Margolius Jr. A, Jackson D.P, Ratnoff O.D. Circulating anticoagulants: a study of 40 cases and a review of the literature. Medicine (Baltimore) 1961; 40: 145-202
    CrossrefPubMedGoogle Scholar
  • 27 Masure R. Les inhibiteurs normaux et pathologiques de la coagulation sanguine. Edition Arscia; Bruxelles: 1960
    Google Scholar
  • 28 Mayer G, Mayer S, Waitz R. Anticoagulant circulant associé à une thrombopénie. Hémostase 1965; 5: 21-36
    PubMedGoogle Scholar
  • 29 Medal L.S, Lisker R. Circulating anticoagulants in disseminated lupus erythematosus. Brit. J. Haemat 1959; 5: 284-293
    CrossrefPubMedGoogle Scholar
  • 30 Nilsson I.M, Skanse B, Gydell K. Circulating anticoagulant after pregnancy and its response to ACTH. Acta haemat. (Basel) 1958; 19: 40-50
    CrossrefPubMedGoogle Scholar
  • 31 Pinkerton P.H, Dagg J.H, Taylor F. A circulating anticoagulant inhibiting antihaemophilic globulin. J. clin. Path 1965; 18: 334-338
    CrossrefPubMedGoogle Scholar
  • 32 Pitney W.R. The assay of antihaemophilic globulin (AHG) in plasma. Brit. J. Haemat 1956; 2: 250-264
    CrossrefPubMedGoogle Scholar
  • 33 Roberts H.R, Scales M.B, Madison J.T, Webster W.P, Penick G.D. A clinical and experimental study of acquired inhibitors to factor VIII. Blood 1965; 26: 805-818
    PubMedGoogle Scholar
  • 34 Rodman Jr. N.F, Barrow E.M, Graham J.B. Diagnosis and control of hemophiloid states with the partial thromboplastin time (PTT) test. Amer. J. clin. Path 1958; 29: 525-538
    PubMedGoogle Scholar
  • 35 Shapiro S.S. The immunologic character of acquired inhibitors of antihemophilic globulin (factor VIII) and the kinetics of their interaction with factor VIII. J. clin. Invest 1967; 46: 147-156
    CrossrefPubMedGoogle Scholar
  • 36 Strauss H.S, Merler E. Characterization and properties of an inhibitor of factor VIII in the plasma of patients with hemophilia A following repeated transfusions. Blood 1967; 30: 137-150
    PubMedGoogle Scholar
  • 37 Whitfield A.G.W, Meynell M.J, Fessey B.M. A circulating anticoagulant occurring after temporal arteritis and controlled by corticosteroid therapy. J. clin. Path 1962; 15: 357-360
    CrossrefPubMedGoogle Scholar
  • 38 Winckelmann G, Overbeck W. Blutgerinnungsprobleme beim extrakorporalen Kreislauf. Klin. Wschr 1961; 39: 333-338
    CrossrefPubMedGoogle Scholar
  • 39 Winterstein A, Marbet R, Strässle R. Kritische Betrachtung zum Thromboplastin-Ge- neration-Test. (Abstr.) Proc. 5th Congr. Europ. Soc. Haemat., Freiburg 1955. Berlin-Göttingen-Heidelberg; Springer: 1956: 803
    Google Scholar